Oversea Chinese Banking Corp Ltd acquired a $30.17 million stake in Regeneron Pharmaceuticals during the first quarter, ...

CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.

This LSPN panel features experts from Maiwald, Regeneron, Vertex Pharmaceuticals, and Taylor Wessing discussing the impact of ...

Morgan Stanley slightly lowered its price target for Regeneron Pharmaceuticals while maintaining an overweight rating, ...

This was the stock's fourth consecutive day of gains.

The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public ...

On the other side, on July 7, JP Morgan analyst Chris Schott reiterated a Buy rating on Regeneron, while maintaining his $800 ...

Jeffrey Hsi, a longtime physics teacher at South High School in the Valley Stream Central High School District, has been ...

A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...

A federal judge on Thursday declined to block the bankruptcy sale of genetic testing company 23andMe to its co-founder Anne ...

Analysts have recently evaluated Regeneron Pharmaceuticals and provided 12-month price targets. The average target is $769.35, accompanied by a high estimate of $975.00 and a low estimate of $547.00.

Following updates by the CDC’s Advisory Committee on Immunization Practices, a coalition of pharmacy organizations has urged insurers to continue to cover vaccines unless there is “clear evidence of ...